Zobrazeno 1 - 10
of 214
pro vyhledávání: '"B. Haworth"'
Autor:
Adam W. Studebaker, Brian J. Hutzen, Christopher R. Pierson, Kellie B. Haworth, Timothy P. Cripe, Eric M. Jackson, Jeffrey R. Leonard
Publikováno v:
Molecular Therapy: Oncolytics, Vol 6, Iss C, Pp 22-30 (2017)
Pediatric brain tumors including medulloblastoma and atypical teratoid/rhabdoid tumor are associated with significant mortality and treatment-associated morbidity. While medulloblastoma tumors within molecular subgroups 3 and 4 have a propensity to m
Externí odkaz:
https://doaj.org/article/43d0e8de0bde4d99ad7c97b2a028b0cf
Autor:
Gregory K Friedman, Elizabeth A Beierle, George Yancey Gillespie, James M Markert, Alicia M Waters, Chun-Yu Chen, Nicholas L Denton, Kellie B Haworth, Brian Hutzen, Jennifer L Leddon, Keri A Streby, Pin-Yi Wang, Timothy P Cripe
Publikováno v:
Molecular Therapy: Oncolytics, Vol 2, Iss , Pp - (2015)
Oncolytic engineered herpes simplex viruses (HSVs) possess many biologic and functional attributes that support their use in clinical trials in children with solid tumors. Tumor cells, in an effort to escape regulatory mechanisms that would impair th
Externí odkaz:
https://doaj.org/article/208f8509998642acba0b4dae3437f353
Autor:
Timothy P Cripe, Chun-Yu Chen, Nicholas L Denton, Kellie B Haworth, Brian Hutzen, Jennifer L Leddon, Keri A Streby, Pin-Yi Wang, James M Markert, Alicia M Waters, George Yancey Gillespie, Elizabeth A Beierle, Gregory K Friedman
Publikováno v:
Molecular Therapy: Oncolytics, Vol 2, Iss , Pp - (2015)
Progress for improving outcomes in pediatric patients with solid tumors remains slow. In addition, currently available therapies are fraught with numerous side effects, often causing significant life-long morbidity for long-term survivors. The use of
Externí odkaz:
https://doaj.org/article/043d5f96330c4eb88f47cb78076352d8
Autor:
Jennifer L Leddon, Chun-Yu Chen, Mark A Currier, Pin-Yi Wang, Francesca A Jung, Nicholas L Denton, Kevin M Cripe, Kellie B Haworth, Michael A Arnold, Amy C Gross, Timothy D Eubank, William F Goins, Joseph C Glorioso, Justus B Cohen, Paola Grandi, David A Hildeman, Timothy P Cripe
Publikováno v:
Molecular Therapy: Oncolytics, Vol 1, Iss C (2014)
Multiple studies have indicated that in addition to direct oncolysis, virotherapy promotes an antitumor cytotoxic T cell response important for efficacy. To study this phenomenon further, we tested three syngeneic murine sarcoma models that displayed
Externí odkaz:
https://doaj.org/article/bf8e7d0411ef44b882998c44c0e17aa8
Publikováno v:
Viruses, Vol 8, Iss 2, p 43 (2016)
Over the past 1–2 decades we have witnessed a resurgence of efforts to therapeutically exploit the attributes of lytic viruses to infect and kill tumor cells while sparing normal cells. We now appreciate that the utility of viruses for treating can
Externí odkaz:
https://doaj.org/article/aab4511464bc46d2a31f932ab594d3c9
Autor:
Kellie B. Haworth
Publikováno v:
Journal of palliative medicine. 23(1)
Autor:
B. Haworth, Giuseppe Forte, L.A. Hollingbery, Gary W. Critchlow, Davide Nocita, Christopher Kay
Publikováno v:
International Journal of Adhesion and Adhesives. 112:103032
The aim of this study was to produce and characterise durable, high-performance super-hydrophilic anti-drip coatings based on water dispersions of true amphiphilic block copolymers, to be utilised on agricultural films. The performance of coated low
Publikováno v:
Rapid Prototyping Journal. 24:93-105
Purpose There is a requirement to match selective laser melting (SLM) technologies to a wider range of polymeric materials, as the existing market for SLM powders is dominated by polyamide PA12. Drivers include the tailoring of physical properties to
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ryan D. Roberts, Jonathan L. Finlay, Nancy Ratner, Timothy P. Cripe, Christopher R. Pierson, Kwangmin Choi, Nicholas D. Yeager, Michael Arnold, Kellie B. Haworth
Publikováno v:
Oncotarget
// Kellie B. Haworth 1, 2 , Michael A. Arnold 3, 4 , Christopher R. Pierson 3, 4, 5 , Kwangmin Choi 6 , Nicholas D. Yeager 1 , Nancy Ratner 6 , Ryan D. Roberts 1, 2 , Jonathan L. Finlay 1 and Timothy P. Cripe 1, 2 1 Division of Hematology, Oncology,